| Product dosage: 180mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.39 | $101.77 (0%) | 🛒 Add to cart |
| 60 | $2.72 | $203.54 $163.23 (20%) | 🛒 Add to cart |
| 90 | $2.51 | $305.31 $225.71 (26%) | 🛒 Add to cart |
| 120 | $2.38 | $407.08 $286.16 (30%) | 🛒 Add to cart |
| 180 | $2.27 | $610.61 $409.09 (33%) | 🛒 Add to cart |
| 270 | $2.20
Best per pill | $915.92 $594.49 (35%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.37 (0%) | 🛒 Add to cart |
| 90 | $0.78 | $74.06 $70.53 (5%) | 🛒 Add to cart |
| 120 | $0.76 | $98.75 $91.69 (7%) | 🛒 Add to cart |
| 180 | $0.74 | $148.12 $133.00 (10%) | 🛒 Add to cart |
| 270 | $0.73 | $222.18 $196.48 (12%) | 🛒 Add to cart |
| 360 | $0.72
Best per pill | $296.24 $258.96 (13%) | 🛒 Add to cart |
Similar products
More info:
diltiazem
Diltiazem hydrochloride is a calcium channel blocker primarily used in cardiovascular medicine, available in various formulations including immediate-release tablets, extended-release capsules, and intravenous preparations. This compound belongs to the benzothiazepine class and has established itself as a cornerstone in managing hypertension, angina pectoris, and certain arrhythmias since its FDA approval in the 1980s. What makes diltiazem particularly valuable in clinical practice is its balanced effect on both vascular smooth muscle and cardiac conduction tissue, though it leans more toward vascular selectivity compared to verapamil.
adalat
Nifedipine, marketed under the brand name Adalat among others, is a calcium channel blocker medication primarily used to manage angina and high blood pressure. It belongs to the dihydropyridine class and functions by relaxing blood vessels, making it easier for the heart to pump blood. Adalat comes in various formulations including immediate-release capsules and extended-release tablets, with the latter providing more stable blood levels for chronic conditions. The development of its extended-release technology actually addressed significant limitations we encountered with the initial formulations—patients were experiencing rapid blood pressure drops and reflex tachycardia that frankly made some clinicians hesitant to prescribe it initially.
bystolic
Bystolic represents one of those interesting cases in cardiovascular pharmacology where we stumbled into something more valuable than we initially anticipated. When I first started prescribing nebivolol back in 2008, most of us viewed it as just another beta-blocker option for hypertension. But over the past fifteen years, I’ve watched this medication reveal dimensions that frankly surprised many cardiologists, myself included. The development team at Forest Laboratories initially focused on its vasodilatory properties, but the real clinical benefits emerged in areas we hadn’t fully anticipated during Phase III trials.
calan
Calan, known generically as verapamil, represents one of the foundational calcium channel blockers in cardiovascular therapeutics. Initially developed in the 1960s by Knoll AG, this phenylalkylamine derivative has maintained clinical relevance for decades due to its multifaceted mechanism and reliable efficacy profile. Unlike dihydropyridine calcium antagonists that predominantly affect vascular smooth muscle, verapamil exhibits significant activity on both cardiac and vascular tissues, making it particularly valuable for rhythm control alongside hypertension management.
cardizem
Cardizem, known generically as diltiazem, is a calcium channel blocker primarily prescribed for managing cardiovascular conditions such as hypertension, chronic stable angina, and certain arrhythmias like atrial fibrillation. It functions by inhibiting calcium ion influx during cardiac and vascular smooth muscle depolarization, leading to reduced peripheral vascular resistance and myocardial oxygen demand. Available in various formulations including immediate-release tablets, extended-release capsules, and intravenous injections, Cardizem is a cornerstone therapy in cardiology due to its efficacy and relatively favorable side effect profile.
coreg
Coreg, known generically as carvedilol, is a beta-blocker with additional alpha-1 blocking properties, primarily used in cardiovascular medicine. It’s not a dietary supplement but a prescription medication approved for treating heart failure, left ventricular dysfunction following myocardial infarction, and hypertension. The unique dual mechanism sets it apart from traditional beta-blockers, offering both hemodynamic benefits and potential antioxidant effects. Coreg: Comprehensive Management of Heart Failure and Hypertension - Evidence-Based Review 1. Introduction: What is Coreg?
Inderal: Comprehensive Cardiovascular and Neurological Protection - Evidence-Based Review
Product Description: Inderal, known generically as propranolol hydrochloride, represents one of the foundational beta-blockers in cardiovascular and neurological therapeutics. As a non-selective beta-adrenergic antagonist, it occupies a unique position in managing conditions ranging from hypertension and angina to essential tremor and migraine prophylaxis. The development of this molecule in the 1960s actually came from investigating compounds that could block the effects of catecholamines on the heart—initially for angina, but we quickly discovered its utility extended far beyond cardiology.
isoptin
Isoptin, known generically as verapamil hydrochloride, is a calcium channel blocker of the phenylalkylamine class. It’s one of those foundational cardiovascular medications that every internist and cardiologist has prescribed thousands of times, yet its nuanced applications continue to surprise even seasoned clinicians. It works primarily by inhibiting the influx of calcium ions through slow channels into cardiac and vascular smooth muscle cells, which leads to coronary and peripheral vasodilation, a reduction in peripheral vascular resistance, and a decrease in myocardial oxygen demand.
Lanoxin: Precise Heart Rate and Rhythm Control for Cardiac Conditions - Evidence-Based Review
Lanoxin, known generically as digoxin, is a cardiac glycoside derived from the foxglove plant (Digitalis lanata). It has been a cornerstone in cardiology for decades, primarily used to manage atrial fibrillation and heart failure. Its mechanism involves inhibiting the sodium-potassium ATPase pump, which increases intracellular calcium and enhances myocardial contractility. Despite newer agents, it remains relevant due to its unique properties and cost-effectiveness. Understanding its pharmacokinetics, therapeutic window, and drug interactions is crucial for safe administration.